Development Level

Tbio 9 | 10,625
Tchem 4 | 1,890
Tclin 1 | 602

IMPC Term

decreased circulating glycerol... 1 | 19

Disease

ovarian cancer 10 | 8,484
Cancer 8 | 2,346
psoriasis 8 | 6,685
invasive ductal carcinoma 6 | 2,950
Epilepsy 5 | 346
Pick disease 5 | 1,893
lung cancer 5 | 4,466
Alzheimer's disease 4 | 644
Heart disease 4 | 279
Hypertension 4 | 287
breast carcinoma 4 | 1,614
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,988
lung adenocarcinoma 4 | 2,713
medulloblastoma, large-cell 4 | 6,234
non-small cell lung cancer 4 | 2,798
osteosarcoma 4 | 7,933
Alcohol dependence 3 | 107
Autistic Disorder 3 | 320
Breast cancer 3 | 3,094
Intellectual disability 3 | 573
Major Depressive Disorder 3 | 106
Multiple Sclerosis 3 | 498
Schizophrenia 3 | 501
cutaneous lupus erythematosus 3 | 1,056
dermatomyositis 3 | 933
diabetes mellitus 3 | 1,663
ductal carcinoma in situ 3 | 1,745
glioblastoma 3 | 5,572
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
lung carcinoma 3 | 2,844
medulloblastoma 3 | 1,524
pilocytic astrocytoma 3 | 3,086
pituitary cancer 3 | 1,972
primary pancreatic ductal adenocarcinoma 3 | 1,271
primitive neuroectodermal tumor 3 | 3,031
tuberculosis 3 | 1,557
ulcerative colitis 3 | 2,087
Anxiety Disorders 2 | 37
Asthma 2 | 349
Cerebral palsy 2 | 28
Cerebrovascular disease 2 | 231
Cocaine-Related Disorders 2 | 88
Dementia 2 | 129
Dystonia 2 | 77
Epilepsy, Temporal Lobe 2 | 23
Gout 2 | 93
Huntington's disease 2 | 72
Hyperactive behavior 2 | 31
Kidney failure 2 | 39
Lung Neoplasms 2 | 171
Migraine 2 | 79
Multiple myeloma 2 | 1,327
Myocardial Infarction 2 | 126
Neoplastic Cell Transformation 2 | 81
Neurodegenerative disease 2 | 383
Nicotine dependence 2 | 53
Obesity 2 | 616
Pain agnosia 2 | 99
Parkinson's disease 2 | 364
Rhinitis 2 | 46
Seizures 2 | 95
Waldenstrons macroglobulinemia 2 | 765
Withdrawal disorder 2 | 19
acute quadriplegic myopathy 2 | 1,157
astrocytoma 2 | 1,493
atypical teratoid / rhabdoid tumor 2 | 4,369
colon cancer 2 | 1,475
group 3 medulloblastoma 2 | 2,254
head and neck cancer and chronic obstructive pulmonary disease 2 | 237
interstitial cystitis 2 | 2,299
juvenile dermatomyositis 2 | 1,189
malignant mesothelioma 2 | 3,162
nasopharyngeal carcinoma 2 | 1,056
oligodendroglioma 2 | 2,849
pancreatic cancer 2 | 2,300
post-traumatic stress disorder 2 | 45
subependymal giant cell astrocytoma 2 | 2,287
tuberculosis and treatment for 6 months 2 | 686
Acquired immunodeficiency syndrome 1 | 164
Alcoholic Intoxication, Chronic 1 | 41
Anorexia 1 | 15
Complex regional pain syndrome 1 | 12
Congenital adrenal hyperplasia 1 | 74
Dental enamel hypoplasia 1 | 12
Developmental Disabilities 1 | 20
Epicondylitis 1 | 19
Fibromyalgia 1 | 22
Hyperuricemia 1 | 35
Intermediate coronary syndrome 1 | 12
Irritable bowel syndrome 1 | 59
Lupus erythematosus 1 | 80
Metabolic acidosis 1 | 49
Myasthenia Gravis 1 | 26
Periodontal disease 1 | 37
Progressive multifocal leukoencephalopathy 1 | 24
Sudden infant death syndrome 1 | 33
Syndactyly 1 | 56
Weight decreased 1 | 18
chronic kidney disease 1 | 90

Tissue

Endocrine System 14 | 18,512
Female tissues 14 | 18,647
Nervous System 14 | 18,561
Blood and immune system 13 | 17,995
Cardiovascular System 13 | 17,958
Digestive Tract 13 | 18,473
Liver and Pancreas 13 | 18,136
Male tissues 13 | 17,969
Respiratory system 13 | 17,484
Skin and soft tissues 13 | 18,115
Urinary Tract 13 | 18,444

Target Family

Non-IDG 8 | 11,971
Enzyme 4 | 4,146
Ion Channel 2 | 341

Grant Application

5P20RR016470-10 14 | 14
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Pro-neuropeptide Y NPY Tbio Non-IDG -3.81741 7285.3 401
NADPH--cytochrome P450 reductase POR Tchem Enzyme -1.99542 103.7 223
MARCKS-related protein MARCKSL1 Tbio Non-IDG -1.63798 45.8 155
Myoglobin MB Tbio Non-IDG -3.92643 8413.2 705
AP-4 complex subunit beta-1 AP4B1 Tbio Non-IDG -0.70524 5.52 100
Hypoxanthine-guanine phosphoribosyltransferase HPRT1 Tchem Enzyme -3.36569 2326.8 278
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
RNA 3'-terminal phosphate cyclase RTCA Tbio Enzyme -1.93078 85.1 78
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
GTPase ERas ERAS Tbio Enzyme -3.23062 1757.5 273